Treatment of Truncated ALK-positive Bone Cancer Using Crizotinib (Xalkori) or Alectinib (Alecensa)

by palligoelme@gmail.com | May 1, 2026 | Clinical Trials

​ Conditions: Bone Cancer; ALK-positive Bone Cancer; Truncated ALK (ALKATI)-Positive Malignancy Interventions: Drug: Alectinib Sponsors: China Medical University Hospital Not yet recruiting Conditions: Bone Cancer; ALK-positive Bone Cancer; Truncated ALK...

[Trial of device that is not approved or cleared by the U.S. FDA]

by palligoelme@gmail.com | May 1, 2026 | Clinical Trials

​ Sponsors: [Redacted] Withheld Sponsors: [Redacted] Withheld 

Disease Activity Monitoring in Patients With Giant Cell Arteritis Study

by palligoelme@gmail.com | May 1, 2026 | Clinical Trials

​ Conditions: Giant Cell Arteritis (GCA) Sponsors: University of Aarhus; Aarhus University Hospital; Aalborg University Hospital; Svendborg Hospital; Glostrup University Hospital, Copenhagen; Vejle Hospital; Horsens Hospital; Regionshospitalet Silkeborg Not yet...

Effect of Beetroot Juice on Cardiovascular and Autonomic Responses to Exercise in Adults With Type 2 Diabetes

by palligoelme@gmail.com | May 1, 2026 | Clinical Trials

​ Conditions: Type 2 Diabetes Mellitus; Hypertension; Autonomic Nervous System Diseases Interventions: Dietary Supplement: Beetroot juice; Dietary Supplement: Nitrate-depleted Beetroot Juice Placebo Sponsors: Oxford Brookes University Not yet recruiting Conditions:...

Measuring AI Reliance Among Intern Doctors in Palestine

by palligoelme@gmail.com | Apr 30, 2026 | Clinical Trials

​ Conditions: Radiology; Internship and Residency; AI (Artificial Intelligence) Interventions: Behavioral: AI prompt (Correct); Behavioral: AI prompt (Incorrect) Sponsors: Al-Quds University Enrolling by invitation Conditions: Radiology; Internship and Residency; AI...